Rheumatoid Arthritis - Pipeline Review, H2 2017

  • ID: 4436064
  • Report
  • 1051 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • 3SBio Inc
  • Bionovis SA
  • Endocyte Inc
  • Japan Tobacco Inc
  • Novartis AG
  • Resverlogix Corp
  • MORE
Rheumatoid Arthritis - Pipeline Review, H2 2017

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2017, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

Rheumatoid arthritis (RA) is an autoimmune chronic disorder that eventually leads to destruction of bones causing deformities. Signs and symptoms of rheumatoid arthritis include tender, warm, swollen joints, fatigue, and fever and weight loss. Rheumatoid arthritis may be a result of genetic and certain specific environmental factors. Women are much more susceptible to develop RA. Treatment includes non-steroidal anti-inflammatory drugs, corticosteroid medications and immunosuppressants.

Report Highlights

The latest Pharmaceutical and Healthcare latest pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Rheumatoid Arthritis (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies / Universities / Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 12, 1, 30, 51, 63, 6, 221, 53 and 9 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 4, 33 and 9 molecules, respectively.

Rheumatoid Arthritis (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis (Immunology).
  • The pipeline guide reviews pipeline therapeutics for Rheumatoid Arthritis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Rheumatoid Arthritis (Immunology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Rheumatoid Arthritis (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Rheumatoid Arthritis (Immunology).
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Rheumatoid Arthritis (Immunology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Rheumatoid Arthritis (Immunology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3SBio Inc
  • Bionovis SA
  • Endocyte Inc
  • Japan Tobacco Inc
  • Novartis AG
  • Resverlogix Corp
  • MORE
Introduction

Rheumatoid Arthritis - Overview

Rheumatoid Arthritis - Therapeutics Development

Rheumatoid Arthritis - Therapeutics Assessment

Rheumatoid Arthritis - Companies Involved in Therapeutics Development

Rheumatoid Arthritis - Drug Profiles

Rheumatoid Arthritis - Dormant Projects

Rheumatoid Arthritis - Discontinued Products

Rheumatoid Arthritis - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Rheumatoid Arthritis, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Products under Development by Companies, H2 2017

Products under Development by Universities/Institutes, H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Rheumatoid Arthritis - Pipeline by 3SBio Inc, H2 2017

Rheumatoid Arthritis - Pipeline by 4D Pharma PLC, H2 2017

Rheumatoid Arthritis - Pipeline by AB Science SA, H2 2017

Rheumatoid Arthritis - Pipeline by AbbVie Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Ablynx NV, H2 2017

Rheumatoid Arthritis - Pipeline by ACEA Biosciences Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Aclaris Therapeutics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Adello Biologics LLC, H2 2017

Rheumatoid Arthritis - Pipeline by Allergan Plc, H2 2017

Rheumatoid Arthritis - Pipeline by Alteogen Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Amarna Therapeutics BV, H2 2017

Rheumatoid Arthritis - Pipeline by Amgen Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Amura Holdings Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Applied Genetic Technologies Corp, H2 2017

Rheumatoid Arthritis - Pipeline by Aptevo Therapeutics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by ARA Healthcare Pvt Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by arGentis Pharmaceuticals LLC, H2 2017

Rheumatoid Arthritis - Pipeline by Arrien Pharmaceuticals LLC, H2 2017

Rheumatoid Arthritis - Pipeline by Arthrogen BV, H2 2017

Rheumatoid Arthritis - Pipeline by Asahi Kasei Pharma Corp, H2 2017

Rheumatoid Arthritis - Pipeline by Astellas Pharma Inc, H2 2017

Rheumatoid Arthritis - Pipeline by AstraZeneca Plc, H2 2017

Rheumatoid Arthritis - Pipeline by Atlantic Bio Sci LLC, H2 2017

Rheumatoid Arthritis - Pipeline by Aurigene Discovery Technologies Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Axsome Therapeutics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Axxam SpA, H2 2017

Rheumatoid Arthritis - Pipeline by Baliopharm AG, H2 2017

Rheumatoid Arthritis - Pipeline by BCN Peptides SA, H2 2017

Rheumatoid Arthritis - Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Bio-Cancer Treatment International Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Biocad, H2 2017

Rheumatoid Arthritis - Pipeline by Biocon Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by BioLingus AG, H2 2017

Rheumatoid Arthritis - Pipeline by BioLite Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Bionovis SA, H2 2017

Rheumatoid Arthritis - Pipeline by Biozeus, H2 2017

Rheumatoid Arthritis - Pipeline by Bird Rock Bio Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Boehringer Ingelheim GmbH, H2 2017

Rheumatoid Arthritis - Pipeline by Bristol-Myers Squibb Co, H2 2017

Rheumatoid Arthritis - Pipeline by BTB Pharma AB, H2 2017

Rheumatoid Arthritis - Pipeline by Cadila Healthcare Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Can-Fite BioPharma Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Cardax Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Carna Biosciences Inc, H2 2017

Rheumatoid Arthritis - Pipeline by CASI Pharmaceuticals Inc, H2 2017

Rheumatoid Arthritis - Pipeline by CEL-SCI Corp, H2 2017

Rheumatoid Arthritis - Pipeline by Celgene Corp, H2 2017

Rheumatoid Arthritis - Pipeline by Cell2B Advanced Therapeutics SA, H2 2017

Rheumatoid Arthritis - Pipeline by Celltrion Inc, H2 2017

Rheumatoid Arthritis - Pipeline by ChemoCentryx Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Chipscreen Biosciences Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by ChironWells GmbH, H2 2017

Rheumatoid Arthritis - Pipeline by Chong Kun Dang Pharmaceutical Corp, H2 2017

Rheumatoid Arthritis - Pipeline by CJ HealthCare Corp, H2 2017

Rheumatoid Arthritis - Pipeline by Clevexel Pharma SAS, H2 2017

Rheumatoid Arthritis - Pipeline by Coherus BioSciences Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Commence Bio Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Compugen Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Crossject SA, H2 2017

Rheumatoid Arthritis - Pipeline by CSL Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Cyclacel Pharmaceuticals Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Daewoong Pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Daiichi Sankyo Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Diamyd Medical AB, H2 2017

Rheumatoid Arthritis - Pipeline by Domainex Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Eisai Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Eli Lilly and Co, H2 2017

Rheumatoid Arthritis - Pipeline by Enceladus Pharmaceuticals BV, H2 2017

Rheumatoid Arthritis - Pipeline by Endocyte Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Enzene Biosciences Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by F. Hoffmann-La Roche Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Fountain Biopharma Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Fresenius SE & Co KGaA, H2 2017

Rheumatoid Arthritis - Pipeline by Fujifilm Holdings Corporation, H2 2017

Rheumatoid Arthritis - Pipeline by Galapagos NV, H2 2017

Rheumatoid Arthritis - Pipeline by Gene Techno Science Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Genentech Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Genfit SA, H2 2017

Rheumatoid Arthritis - Pipeline by Genor BioPharma Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Genosco Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Gilead Sciences Inc, H2 2017

Rheumatoid Arthritis - Pipeline by GlaxoSmithKline Plc, H2 2017

Rheumatoid Arthritis - Pipeline by Griffin Discoveries BV, H2 2017

Rheumatoid Arthritis - Pipeline by Han Wha Pharma Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Hansa Medical AB, H2 2017

Rheumatoid Arthritis - Pipeline by Hanwha Chemical Corp, H2 2017

Rheumatoid Arthritis - Pipeline by Hetero Drugs Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by HitGen LTD, H2 2017

Rheumatoid Arthritis - Pipeline by Huabo Biopharm Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Hutchison MediPharma Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Idogen AB, H2 2017

Rheumatoid Arthritis - Pipeline by Immune Response BioPharma Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Immungenetics AG, H2 2017

Rheumatoid Arthritis - Pipeline by ImmunoFrontier Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Immunwork Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Innate Pharma SA, H2 2017

Rheumatoid Arthritis - Pipeline by Innovent Biologics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Intas Pharmaceuticals Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Istesso Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Japan Tobacco Inc, H2 2017

Rheumatoid Arthritis - Pipeline by JHL Biotech Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Johnson & Johnson, H2 2017

Rheumatoid Arthritis - Pipeline by Jyant Technologies Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Kadmon Corp LLC, H2 2017

Rheumatoid Arthritis - Pipeline by KAHR medical Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Kang Stem Biotech Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Karyopharm Therapeutics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by KPI Therapeutics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Lead Pharma Holding BV, H2 2017

Rheumatoid Arthritis - Pipeline by LG Chem Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Lipocure Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Livzon Pharmaceutical Group Inc, H2 2017

Rheumatoid Arthritis - Pipeline by LSK BioPartners Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Lupin Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Mabion SA, H2 2017

Rheumatoid Arthritis - Pipeline by mAbxience SA, H2 2017

Rheumatoid Arthritis - Pipeline by MacroGenics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Maruho Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Mebiopharm Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by MedAnnex Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Medestea Research & Production SpA, H2 2017

Rheumatoid Arthritis - Pipeline by MedImmune LLC, H2 2017

Rheumatoid Arthritis - Pipeline by Merck & Co Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Merck KGaA, H2 2017

Rheumatoid Arthritis - Pipeline by Mesoblast Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Millennium Pharmaceuticals Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2017

Rheumatoid Arthritis - Pipeline by ModiQuest Group, H2 2017

Rheumatoid Arthritis - Pipeline by Momenta Pharmaceuticals Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Morphotek Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Mycenax Biotech Inc, H2 2017

Rheumatoid Arthritis - Pipeline by MYOS RENS Technology Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Myungmoon pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Navigen Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Nissan Chemical Industries Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Novartis AG, H2 2017

Rheumatoid Arthritis - Pipeline by NovelMed Therapeutics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by NovImmune SA, H2 2017

Rheumatoid Arthritis - Pipeline by Nuevolution AB, H2 2017

Rheumatoid Arthritis - Pipeline by Numab Innovation AG, H2 2017

Rheumatoid Arthritis - Pipeline by Omeros Corp, H2 2017

Rheumatoid Arthritis - Pipeline by Oncobiologics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Oncodesign SA, H2 2017

Rheumatoid Arthritis - Pipeline by OncoImmune Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Ono Pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by OSE Immunotherapeutics, H2 2017

Rheumatoid Arthritis - Pipeline by Paras Biopharmaceuticals Finland Oy, H2 2017

Rheumatoid Arthritis - Pipeline by Peptinov SAS, H2 2017

Rheumatoid Arthritis - Pipeline by Pfenex Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Pfizer Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Pharmacyclics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Pharmascience Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Pharmedartis GmbH, H2 2017

Rheumatoid Arthritis - Pipeline by Philogen SpA, H2 2017

Rheumatoid Arthritis - Pipeline by PlantForm Corp, H2 2017

Rheumatoid Arthritis - Pipeline by PLx Pharma Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Principia Biopharma Inc, H2 2017

Rheumatoid Arthritis - Pipeline by ProNoxis AB, H2 2017

Rheumatoid Arthritis - Pipeline by Protab Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Protalex Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Protalix BioTherapeutics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Qilu Pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Qu Biologics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by R Pharm, H2 2017

Rheumatoid Arthritis - Pipeline by ReceptoPharm Inc, H2 2017

Rheumatoid Arthritis - Pipeline by RedHill Biopharma Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Reliance Life Sciences Pvt Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Resverlogix Corp, H2 2017

Rheumatoid Arthritis - Pipeline by ReveraGen BioPharma Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Rhizen Pharmaceuticals SA, H2 2017

Rheumatoid Arthritis - Pipeline by Ribomic Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Richter Gedeon Nyrt, H2 2017

Rheumatoid Arthritis - Pipeline by Rottapharm Biotech Srl, H2 2017

Rheumatoid Arthritis - Pipeline by Saje Pharma LLC, H2 2017

Rheumatoid Arthritis - Pipeline by Sandoz International GmbH, H2 2017

Rheumatoid Arthritis - Pipeline by Sareum Holdings Plc, H2 2017

Rheumatoid Arthritis - Pipeline by SBI Biotech Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Selecta Biosciences Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Shanghai Pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Shenzhen Salubris Pharmaceuticals Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Synermore Biologics Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Synovo GmbH, H2 2017

Rheumatoid Arthritis - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Teijin Pharma Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by TheraMAB LLC, H2 2017

Rheumatoid Arthritis - Pipeline by Tiziana Life Sciences Plc, H2 2017

Rheumatoid Arthritis - Pipeline by Toleranzia AB, H2 2017

Rheumatoid Arthritis - Pipeline by TTY Biopharm Company Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Tumorend LLC, H2 2017

Rheumatoid Arthritis - Pipeline by Twoxar Inc, H2 2017

Rheumatoid Arthritis - Pipeline by TxCell SA, H2 2017

Rheumatoid Arthritis - Pipeline by U.S. Stem Cell Inc, H2 2017

Rheumatoid Arthritis - Pipeline by UCB SA, H2 2017

Rheumatoid Arthritis - Pipeline by United BioPharma Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Vaccinex Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Valeant Pharmaceuticals International Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Vicore Pharma AB, H2 2017

Rheumatoid Arthritis - Pipeline by viDA Therapeutics Inc, H2 2017

Rheumatoid Arthritis - Pipeline by Xbrane Biopharma AB, H2 2017

Rheumatoid Arthritis - Pipeline by Xencor Inc, H2 2017

Rheumatoid Arthritis - Pipeline by XL-protein GmbH, H2 2017

Rheumatoid Arthritis - Pipeline by Yungjin Pharm Co Ltd, H2 2017

Rheumatoid Arthritis - Pipeline by Yuyu Pharma Inc, H2 2017

Rheumatoid Arthritis - Dormant Projects, H2 2017

Rheumatoid Arthritis - Discontinued Products, H2 2017

List of Figures

Number of Products under Development for Rheumatoid Arthritis, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products by Top 10 Targets, H2 2017

Number of Products by Stage and Top 10 Targets, H2 2017

Number of Products by Top 10 Mechanism of Actions, H2 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017

Number of Products by Routes of Administration, H2 2017

Number of Products by Stage and Routes of Administration, H2 2017

Number of Products by Top 10 Molecule Types, H2 2017

Number of Products by Stage and Top 10 Molecule Types, H2
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 3SBio Inc
  • 4D Pharma PLC
  • AB Science SA
  • AbbVie Inc
  • Ablynx NV
  • ACEA Biosciences Inc
  • Aclaris Therapeutics Inc
  • Adello Biologics LLC
  • Allergan Plc
  • Alteogen Inc
  • Amarna Therapeutics BV
  • Amgen Inc
  • Amura Holdings Ltd
  • Applied Genetic Technologies Corp
  • Aptevo Therapeutics Inc
  • ARA Healthcare Pvt Ltd
  • arGentis Pharmaceuticals LLC
  • Arrien Pharmaceuticals LLC
  • Arthrogen BV
  • Asahi Kasei Pharma Corp
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Atlantic Bio Sci LLC
  • Aurigene Discovery Technologies Ltd
  • Axsome Therapeutics Inc
  • Axxam SpA
  • Baliopharm AG
  • BCN Peptides SA
  • Beijing Hanmi Pharmaceutical Co Ltd
  • Bio-Cancer Treatment International Ltd
  • Biocad
  • Biocon Ltd
  • BioLingus AG
  • BioLite Inc
  • Bionovis SA
  • Biozeus
  • Bird Rock Bio Inc
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Co
  • BTB Pharma AB
  • Cadila Healthcare Ltd
  • Can-Fite BioPharma Ltd
  • Cardax Inc
  • Carna Biosciences Inc
  • CASI Pharmaceuticals Inc
  • CEL-SCI Corp
  • Celgene Corp
  • Cell2B Advanced Therapeutics SA
  • Celltrion Inc
  • ChemoCentryx Inc
  • Chipscreen Biosciences Ltd
  • ChironWells GmbH
  • Chong Kun Dang Pharmaceutical Corp
  • CJ HealthCare Corp
  • Clevexel Pharma SAS
  • Coherus BioSciences Inc
  • Commence Bio Inc
  • Compugen Ltd
  • Crossject SA
  • CSL Ltd
  • Cyclacel Pharmaceuticals Inc
  • Daewoong Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • Diamyd Medical AB
  • Domainex Ltd
  • Dr. Reddy's Laboratories Ltd
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Enceladus Pharmaceuticals BV
  • Endocyte Inc
  • Enzene Biosciences Ltd
  • F. Hoffmann-La Roche Ltd
  • Fountain Biopharma Inc
  • Fresenius SE & Co KGaA
  • Fujifilm Holdings Corporation
  • Galapagos NV
  • Gene Techno Science Co Ltd
  • Genentech Inc
  • Genfit SA
  • Genor BioPharma Co Ltd
  • Genosco Inc
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Griffin Discoveries BV
  • Han Wha Pharma Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • Hansa Medical AB
  • Hanwha Chemical Corp
  • Hetero Drugs Ltd
  • HitGen LTD
  • Huabo Biopharm Co Ltd
  • Hutchison MediPharma Ltd
  • Idogen AB
  • Immune Response BioPharma Inc
  • Immungenetics AG
  • ImmunoFrontier Inc
  • Immunwork Inc
  • Innate Pharma SA
  • Innovent Biologics Inc
  • Intas Pharmaceuticals Ltd
  • Istesso Ltd
  • Japan Tobacco Inc
  • JHL Biotech Inc
  • Jiangsu Hengrui Medicine Co Ltd
  • Johnson & Johnson
  • Jyant Technologies Inc
  • Kadmon Corp LLC
  • KAHR medical Ltd
  • Kang Stem Biotech Co Ltd
  • Karyopharm Therapeutics Inc
  • KPI Therapeutics Inc
  • Lead Pharma Holding BV
  • LG Chem Ltd
  • Lipocure Ltd
  • Livzon Pharmaceutical Group Inc
  • LSK BioPartners Inc
  • Lupin Ltd
  • Mabion SA
  • mAbxience SA
  • MacroGenics Inc
  • Maruho Co Ltd
  • Mebiopharm Co Ltd
  • MedAnnex Ltd
  • Medestea Research & Production SpA
  • MedImmune LLC
  • Merck & Co Inc
  • Merck KGaA
  • Mesoblast Ltd
  • Millennium Pharmaceuticals Inc
  • Mitsubishi Tanabe Pharma Corp
  • ModiQuest Group
  • Momenta Pharmaceuticals Inc
  • Morphotek Inc
  • Mycenax Biotech Inc
  • MYOS RENS Technology Inc
  • Myungmoon pharmaceutical Co Ltd
  • Navigen Inc
  • Nichi-Iko Pharmaceutical Co Ltd
  • Nissan Chemical Industries Ltd
  • Novartis AG
  • NovelMed Therapeutics Inc
  • NovImmune SA
  • Nuevolution AB
  • Numab Innovation AG
  • Omeros Corp
  • Oncobiologics Inc
  • Oncodesign SA
  • OncoImmune Inc
  • Ono Pharmaceutical Co Ltd
  • OSE Immunotherapeutics
  • Paras Biopharmaceuticals Finland Oy
  • Peptinov SAS
  • Pfenex Inc
  • Pfizer Inc
  • Pharmacyclics Inc
  • Pharmascience Inc
  • Pharmedartis GmbH
  • Philogen SpA
  • PlantForm Corp
  • PLx Pharma Inc
  • Principia Biopharma Inc
  • ProNoxis AB
  • Protab Ltd
  • Protalex Inc
  • Protalix BioTherapeutics Inc
  • Qilu Pharmaceutical Co Ltd
  • Qu Biologics Inc
  • R Pharm
  • ReceptoPharm Inc
  • RedHill Biopharma Ltd
  • Reliance Life Sciences Pvt Ltd
  • Resverlogix Corp
  • ReveraGen BioPharma Inc
  • Rhizen Pharmaceuticals SA
  • Ribomic Inc
  • Richter Gedeon Nyrt
  • Rottapharm Biotech Srl
  • Saje Pharma LLC
  • Sandoz International GmbH
  • Sareum Holdings Plc
  • SBI Biotech Co Ltd
  • Selecta Biosciences Inc
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
  • Shanghai Pharmaceutical Co Ltd
  • Shenzhen Salubris Pharmaceuticals Co Ltd
  • Synermore Biologics Co Ltd
  • Synovo GmbH
  • Takeda Pharmaceutical Co Ltd
  • Teijin Pharma Ltd
  • TheraMAB LLC
  • Tiziana Life Sciences Plc
  • Toleranzia AB
  • TTY Biopharm Company Ltd
  • Tumorend LLC
  • Twoxar Inc
  • TxCell SA
  • U.S. Stem Cell Inc
  • UCB SA
  • United BioPharma Inc
  • Vaccinex Inc
  • Valeant Pharmaceuticals International Inc
  • Vicore Pharma AB
  • viDA Therapeutics Inc
  • Xbrane Biopharma AB
  • Xencor Inc
  • XL-protein GmbH
  • Yungjin Pharm Co Ltd
  • Yuyu Pharma Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll